Inventor · disambiguated record
John Gagnon
Also filed as: GAGNON JOHN · GAGNON JOHN D
3 granted patents·7 pending applications·4 citations·filing 2020–2025
60Inventor score
Top patents by PatentIndex Score
10 records- 0188US11304978B2Compositions and methods for the treatment of cancer using a CD8 engineered T cell therapyPACT PHARMA INC·Filed 2020·Granted Apr 19, 2022·2 cites·24 claims
- 0287US12037407B2Immune cells having co-expressed shRNAS and logic gate systemsARSENAL BIOSCIENCES INC·Filed 2023·Granted Jul 16, 2024·2 cites·71 claims
- 0372US12247061B2Compositions and methods for the treatment of cancer using a CD8 engineered T cell therapyADOC SSF LLC·Filed 2022·Granted Mar 11, 2025·0 cites·11 claims
- 0472US2024309106A1Immune cells having co-expressed shrnas and logic gate systemsARSENAL BIOSCIENCES INC·Filed 2024·Application pending·0 cites
- 0565US2021085720A1Compositions and methods for the treatment of cancer using a tet2 engineered t cell therapyPACT PHARMA INC·Filed 2020·Application pending·0 cites
- 0660US2025250350A1Immune cells having co-expressed shrnas and logic gate systemsArsenal Biosciences·Filed 2025·Application pending·0 cites
- 0760US2024066063A1COMPOSITIONS AND METHODS FOR THE TREATMENT OF CANCER USING A TGFßRII ENGINEERED T CELL THERAPYPACT PHARMA INC·Filed 2023·Application pending·0 cites
- 0852US2022235380A1Immune cells having co-expressed shrnas and logic gate systemsARSENAL BIOSCIENCES INC·Filed 2022·Application pending·0 cites
- 0941US2025215438A1Immune cells having co-expressed tgfbr shrnasARSENAL BIOSCIENCES INC·Filed 2025·Application pending·0 cites
- 1039US2025222103A1Immune cells with combination gene perturbationsARSENAL BIOSCIENCES INC·Filed 2025·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when John Gagnon files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →